UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) February 4, 2020
HUNTINGTON BANCSHARES INCORPORATED
(Exact name of registrant as specified in its charter)
|
|
|
|
|
| Maryland |
|
1-34073 |
|
31-0724920 |
| (State or other jurisdiction of incorporation or organization) |
|
(Commission File Number) |
|
(I.R.S. Employer Identification No.) |
Registrant’s address: 41 South High Street, Columbus, Ohio 43287
Registrant’s telephone number, including area code: (614) 480-2265
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
| Title of Class |
|
Trading Symbol(s) |
|
Name of exchange on which registered |
| 5.875% Series C Non-Cumulative, perpetual preferred stock |
|
HBANN |
|
NASDAQ |
| 6.250% Series D Non-Cumulative, perpetual preferred stock |
|
HBANO |
|
NASDAQ |
| Common Stock—Par Value $0.01 per Share |
|
HBAN |
|
NASDAQ |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01. Other Events
On February 4, 2020, Huntington Bancshares Incorporated (the “Company”) issued and sold $750,000,000 aggregate principal amount of its 2.550% Senior Notes due 2030 (the “Notes”). The Notes were issued pursuant to a Senior Debt Indenture, dated as of July 30, 2019, between the Company and Deutsche Bank Trust Company Americas (the “Trustee”), as amended and supplemented by a Second Supplemental Indenture, dated as of February 4, 2020, between the Company and the Trustee (the “Second Supplemental Indenture”). The Notes were sold pursuant to an underwriting agreement (the “Underwriting Agreement”), dated as of January 28, 2020, by and among the Company and, on behalf of themselves and the several underwriters named therein, Morgan Stanley & Co. LLC, Credit Suisse Securities (USA) LLC, The Huntington Investment Company, J.P. Morgan Securities LLC and RBC Capital Markets, LLC.
The Second Supplemental Indenture and the Notes are attached to this Current Report on Form 8-K as Exhibit 4.1 and Exhibit 4.2, respectively, and are incorporated into this Item 8.01 by reference. The Underwriting Agreement, the Second Supplemental Indenture and the Notes are more fully described in a prospectus supplement, dated January 28, 2020, filed with the U.S. Securities and Exchange Commission (the “Commission”) on January 29, 2020, to the accompanying prospectus filed with the Commission on July 30, 2019, as part of the Company’s Registration Statement on Form S-3ASR (File No. 333-232886).
The foregoing descriptions of the Second Supplemental Indenture and the Notes do not purport to be complete and are qualified in their entirety by reference to Exhibit 4.1 and Exhibit 4.2, respectively.
Concurrently with this offering, the Company’s bank subsidiary, The Huntington National Bank, issued and sold $500,000,000 aggregate principal amount of its 1.800% Senior Notes due 2023.
This Current Report on Form 8-K is being filed, in part, for the purpose of filing the documents in connection with the issuance of the Notes and such exhibits are hereby incorporated into the Company’s Registration Statement on Form S-3ASR (File No. 333-232886).
Item 9.01. Financial Statements and Exhibits.